TITLE:
A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies

CONDITION:
HIV Infections

INTERVENTION:
Delavirdine mesylate

SUMMARY:

      The purpose of this study is to see if it is safe and effective to give delavirdine mesylate
      (Rescriptor) plus two nucleoside reverse transcriptase inhibitors (NRTIs) to HIV-infected
      children and babies. This study also examines how the body processes Rescriptor when taken
      with 2 NRTIs.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 1 Month to 15 Years
Criteria:

        Inclusion Criteria

        Patients must have:

          -  HIV infection.

          -  Plasma HIV-1 levels greater than 10,000 copies/ml.
      
